Business Card for Fred Cannon:


Process Manager
Ridgefield, CT area


900 Ridgebury Rd
Ridgefield, CT 06877

Tel: (203) 798-9988

Last updated on 2017-08-16


About Fred Cannon:

Fred Cannon works as an Process Manager for Boehringer Ingelheim GmbH at Ridgefield, CT. The company's webpage is http://www.boehringer-ingelheim.com. For email, phone number and executive profiles for Process Manager and other executives of Boehringer Ingelheim GmbH at Ridgefield, CT, check Boehringer Ingelheim GmbH at Joesdata.com. Not the Fred Cannon you are looking for? Do a quick search in our website and find other people named Fred Cannon.
Fred Cannon's Work History:
No information available..

Fred Cannon's Education:
No information available..

Fred Cannon's Co-workers:
As of October 27, 2020, Fred Cannon has 527 co-workers under the company name Boehringer Ingelheim GmbH at Joesdata.com.

About Boehringer Ingelheim GmbH:

Boehringer Ingelheim GmbH is located at 900 Ridgebury Rd , Ridgefield, CT 06877. It has over 10K employees. Its revenue is over $1B.

Company News:
2018-09-17 19:18:47
Large European real-world study reports effects of Spiolto Respimat for people living with COPD in daily clinical practice1
2018-09-13 17:49:03
Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
2018-09-13 17:12:15
Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
2018-09-04 18:00:25
Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
2018-09-04 17:30:29
Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
2018-08-20 18:25:00
Boehringer Ingelheim: New sub-analyses to be presented at ESC Congress 2018 further support positive safety profile of Pradaxa (dabigatran etexilate)
2018-08-20 17:30:45
Boehringer Ingelheim: New sub-analyses to be presented at ESC Congress 2018 further support positive safety profile of Pradaxa (dabigatran etexilate)
2018-08-06 17:30:49
Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis
2018-08-06 17:06:30
Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis
2018-08-02 17:06:30
Boehringer Ingelheim launches the initiative In Reach Africa to address key healthcare infrastructure and access priorities across Africa

People in the same industry:

Chad Hammerstrom
VP Net-Rx Services
Net-Rx

Michael Bill
Vice President Technologies
Advanced Vision Research, Inc.

James Hockley
Information Technology Staff
Summit Research Network (Michigan) Inc.

Sara Jull
Dir Project Management
Coldstream Laboratories, Inc

Andrew Howe
Chief Operating Officer
Red Nucleus

Joshua Knox
Information Technology Coordinator
QoL Meds